Metastatic Renal Cell Carcinoma Completed Phase 2 Trials for Interferon alfa-2a, Recombinant (DB00034)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01731158Sequential Therapy in Metastatic Renal Cell CarinomaTreatment
NCT00619268Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell CarcinomaTreatment